Global Octreotide Drugs Market Insights, Forecast to 2030

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Octreotide Drugs Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Octreotide Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 Injections
  • 1.2.3 Oral Capsules
• 1.3 Market by Application
  • 1.3.1 Global Octreotide Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Neuroendocrine Tumors
  • 1.3.3 Acromegaly
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Octreotide Drugs Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Octreotide Drugs Revenue by Region
  • 2.2.1 Global Octreotide Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Octreotide Drugs Revenue by Region (2019-2024)
  • 2.2.3 Global Octreotide Drugs Revenue by Region (2025-2030)
  • 2.2.4 Global Octreotide Drugs Revenue Market Share by Region (2019-2030)
• 2.3 Global Octreotide Drugs Sales Estimates and Forecasts 2019-2030
• 2.4 Global Octreotide Drugs Sales by Region
  • 2.4.1 Global Octreotide Drugs Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Octreotide Drugs Sales by Region (2019-2024)
  • 2.4.3 Global Octreotide Drugs Sales by Region (2025-2030)
  • 2.4.4 Global Octreotide Drugs Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Octreotide Drugs Sales by Manufacturers
  • 3.1.1 Global Octreotide Drugs Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Octreotide Drugs Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Octreotide Drugs in 2023
• 3.2 Global Octreotide Drugs Revenue by Manufacturers
  • 3.2.1 Global Octreotide Drugs Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Octreotide Drugs Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Octreotide Drugs Revenue in 2023
• 3.3 Global Key Players of Octreotide Drugs, Industry Ranking, 2021 VS 2022
• 3.4 Global Octreotide Drugs Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Octreotide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Octreotide Drugs, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Octreotide Drugs, Product Offered and Application
• 3.8 Global Key Manufacturers of Octreotide Drugs, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Octreotide Drugs Sales by Type
  • 4.1.1 Global Octreotide Drugs Historical Sales by Type (2019-2024)
  • 4.1.2 Global Octreotide Drugs Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Octreotide Drugs Sales Market Share by Type (2019-2030)
• 4.2 Global Octreotide Drugs Revenue by Type
  • 4.2.1 Global Octreotide Drugs Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Octreotide Drugs Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Octreotide Drugs Revenue Market Share by Type (2019-2030)
• 4.3 Global Octreotide Drugs Price by Type
  • 4.3.1 Global Octreotide Drugs Price by Type (2019-2024)
  • 4.3.2 Global Octreotide Drugs Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Octreotide Drugs Sales by Application
  • 5.1.1 Global Octreotide Drugs Historical Sales by Application (2019-2024)
  • 5.1.2 Global Octreotide Drugs Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Octreotide Drugs Sales Market Share by Application (2019-2030)
• 5.2 Global Octreotide Drugs Revenue by Application
  • 5.2.1 Global Octreotide Drugs Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Octreotide Drugs Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Octreotide Drugs Revenue Market Share by Application (2019-2030)
• 5.3 Global Octreotide Drugs Price by Application
  • 5.3.1 Global Octreotide Drugs Price by Application (2019-2024)
  • 5.3.2 Global Octreotide Drugs Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Octreotide Drugs Market Size by Type
  • 6.1.1 US & Canada Octreotide Drugs Sales by Type (2019-2030)
  • 6.1.2 US & Canada Octreotide Drugs Revenue by Type (2019-2030)
• 6.2 US & Canada Octreotide Drugs Market Size by Application
  • 6.2.1 US & Canada Octreotide Drugs Sales by Application (2019-2030)
  • 6.2.2 US & Canada Octreotide Drugs Revenue by Application (2019-2030)
• 6.3 US & Canada Octreotide Drugs Market Size by Country
  • 6.3.1 US & Canada Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Octreotide Drugs Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Octreotide Drugs Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Octreotide Drugs Market Size by Type
  • 7.1.1 Europe Octreotide Drugs Sales by Type (2019-2030)
  • 7.1.2 Europe Octreotide Drugs Revenue by Type (2019-2030)
• 7.2 Europe Octreotide Drugs Market Size by Application
  • 7.2.1 Europe Octreotide Drugs Sales by Application (2019-2030)
  • 7.2.2 Europe Octreotide Drugs Revenue by Application (2019-2030)
• 7.3 Europe Octreotide Drugs Market Size by Country
  • 7.3.1 Europe Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Octreotide Drugs Revenue by Country (2019-2030)
  • 7.3.3 Europe Octreotide Drugs Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Octreotide Drugs Market Size by Type
  • 8.1.1 China Octreotide Drugs Sales by Type (2019-2030)
  • 8.1.2 China Octreotide Drugs Revenue by Type (2019-2030)
• 8.2 China Octreotide Drugs Market Size by Application
  • 8.2.1 China Octreotide Drugs Sales by Application (2019-2030)
  • 8.2.2 China Octreotide Drugs Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Octreotide Drugs Market Size by Type
  • 9.1.1 Asia Octreotide Drugs Sales by Type (2019-2030)
  • 9.1.2 Asia Octreotide Drugs Revenue by Type (2019-2030)
• 9.2 Asia Octreotide Drugs Market Size by Application
  • 9.2.1 Asia Octreotide Drugs Sales by Application (2019-2030)
  • 9.2.2 Asia Octreotide Drugs Revenue by Application (2019-2030)
• 9.3 Asia Octreotide Drugs Market Size by Region
  • 9.3.1 Asia Octreotide Drugs Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Octreotide Drugs Revenue by Region (2019-2030)
  • 9.3.3 Asia Octreotide Drugs Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Octreotide Drugs Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Octreotide Drugs Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Octreotide Drugs Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Octreotide Drugs Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Octreotide Drugs Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Octreotide Drugs Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Octreotide Drugs Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Octreotide Drugs Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Octreotide Drugs Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Octreotide Drugs Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Novartis
  • 11.1.1 Novartis Company Information
  • 11.1.2 Novartis Overview
  • 11.1.3 Novartis Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Novartis Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Novartis Recent Developments
• 11.2 Sun Pharmaceutical
  • 11.2.1 Sun Pharmaceutical Company Information
  • 11.2.2 Sun Pharmaceutical Overview
  • 11.2.3 Sun Pharmaceutical Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Sun Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Sun Pharmaceutical Recent Developments
• 11.3 Teva
  • 11.3.1 Teva Company Information
  • 11.3.2 Teva Overview
  • 11.3.3 Teva Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.3.4 Teva Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.3.5 Teva Recent Developments
• 11.4 Gland Pharma
  • 11.4.1 Gland Pharma Company Information
  • 11.4.2 Gland Pharma Overview
  • 11.4.3 Gland Pharma Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.4.4 Gland Pharma Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.4.5 Gland Pharma Recent Developments
• 11.5 Chiesi Farmaceutici S.p.A
  • 11.5.1 Chiesi Farmaceutici S.p.A Company Information
  • 11.5.2 Chiesi Farmaceutici S.p.A Overview
  • 11.5.3 Chiesi Farmaceutici S.p.A Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.5.4 Chiesi Farmaceutici S.p.A Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.5.5 Chiesi Farmaceutici S.p.A Recent Developments
• 11.6 Fresenius Kabi
  • 11.6.1 Fresenius Kabi Company Information
  • 11.6.2 Fresenius Kabi Overview
  • 11.6.3 Fresenius Kabi Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.6.4 Fresenius Kabi Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.6.5 Fresenius Kabi Recent Developments
• 11.7 Mylan
  • 11.7.1 Mylan Company Information
  • 11.7.2 Mylan Overview
  • 11.7.3 Mylan Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.7.4 Mylan Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.7.5 Mylan Recent Developments
• 11.8 Sagent Pharmaceuticals
  • 11.8.1 Sagent Pharmaceuticals Company Information
  • 11.8.2 Sagent Pharmaceuticals Overview
  • 11.8.3 Sagent Pharmaceuticals Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.8.4 Sagent Pharmaceuticals Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.8.5 Sagent Pharmaceuticals Recent Developments
• 11.9 West-Ward Pharmaceuticals
  • 11.9.1 West-Ward Pharmaceuticals Company Information
  • 11.9.2 West-Ward Pharmaceuticals Overview
  • 11.9.3 West-Ward Pharmaceuticals Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.9.4 West-Ward Pharmaceuticals Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.9.5 West-Ward Pharmaceuticals Recent Developments
• 11.10 Suzhou Tianma Pharmaceutical
  • 11.10.1 Suzhou Tianma Pharmaceutical Company Information
  • 11.10.2 Suzhou Tianma Pharmaceutical Overview
  • 11.10.3 Suzhou Tianma Pharmaceutical Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.10.4 Suzhou Tianma Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.10.5 Suzhou Tianma Pharmaceutical Recent Developments
• 11.11 Sihuan Pharmaceutical
  • 11.11.1 Sihuan Pharmaceutical Company Information
  • 11.11.2 Sihuan Pharmaceutical Overview
  • 11.11.3 Sihuan Pharmaceutical Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.11.4 Sihuan Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.11.5 Sihuan Pharmaceutical Recent Developments
• 11.12 Chengdu Tiantaishan pharmaceutical
  • 11.12.1 Chengdu Tiantaishan pharmaceutical Company Information
  • 11.12.2 Chengdu Tiantaishan pharmaceutical Overview
  • 11.12.3 Chengdu Tiantaishan pharmaceutical Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.12.4 Chengdu Tiantaishan pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.12.5 Chengdu Tiantaishan pharmaceutical Recent Developments
• 11.13 Hybio Pharmaceutical
  • 11.13.1 Hybio Pharmaceutical Company Information
  • 11.13.2 Hybio Pharmaceutical Overview
  • 11.13.3 Hybio Pharmaceutical Octreotide Drugs Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.13.4 Hybio Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.13.5 Hybio Pharmaceutical Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Octreotide Drugs Industry Chain Analysis
• 12.2 Octreotide Drugs Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Octreotide Drugs Production Mode & Process
• 12.4 Octreotide Drugs Sales and Marketing
  • 12.4.1 Octreotide Drugs Sales Channels
  • 12.4.2 Octreotide Drugs Distributors
• 12.5 Octreotide Drugs Customers

13 Octreotide Drugs Market Dynamics

• 13.1 Octreotide Drugs Industry Trends
• 13.2 Octreotide Drugs Market Drivers
• 13.3 Octreotide Drugs Market Challenges
• 13.4 Octreotide Drugs Market Restraints

14 Key Findings in the Global Octreotide Drugs Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer

List of Tables

Table 1. Global Octreotide Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Injections

Table 3. Major Manufacturers of Oral Capsules

Table 4. Global Octreotide Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Octreotide Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Octreotide Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Octreotide Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Octreotide Drugs Revenue Market Share by Region (2019-2024)

Table 9. Global Octreotide Drugs Revenue Market Share by Region (2025-2030)

Table 10. Global Octreotide Drugs Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Octreotide Drugs Sales by Region (2019-2024) & (K Units)

Table 12. Global Octreotide Drugs Sales by Region (2025-2030) & (K Units)

Table 13. Global Octreotide Drugs Sales Market Share by Region (2019-2024)

Table 14. Global Octreotide Drugs Sales Market Share by Region (2025-2030)

Table 15. Global Octreotide Drugs Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Octreotide Drugs Sales Share by Manufacturers (2019-2024)

Table 17. Global Octreotide Drugs Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Octreotide Drugs Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Octreotide Drugs, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Octreotide Drugs Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Octreotide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Octreotide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Octreotide Drugs as of 2023)

Table 23. Global Key Manufacturers of Octreotide Drugs, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Octreotide Drugs, Product Offered and Application

Table 25. Global Key Manufacturers of Octreotide Drugs, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Octreotide Drugs Sales by Type (2019-2024) & (K Units)

Table 28. Global Octreotide Drugs Sales by Type (2025-2030) & (K Units)

Table 29. Global Octreotide Drugs Sales Share by Type (2019-2024)

Table 30. Global Octreotide Drugs Sales Share by Type (2025-2030)

Table 31. Global Octreotide Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Octreotide Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Octreotide Drugs Revenue Share by Type (2019-2024)

Table 34. Global Octreotide Drugs Revenue Share by Type (2025-2030)

Table 35. Octreotide Drugs Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Octreotide Drugs Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Octreotide Drugs Sales by Application (2019-2024) & (K Units)

Table 38. Global Octreotide Drugs Sales by Application (2025-2030) & (K Units)

Table 39. Global Octreotide Drugs Sales Share by Application (2019-2024)

Table 40. Global Octreotide Drugs Sales Share by Application (2025-2030)

Table 41. Global Octreotide Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Octreotide Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Octreotide Drugs Revenue Share by Application (2019-2024)

Table 44. Global Octreotide Drugs Revenue Share by Application (2025-2030)

Table 45. Octreotide Drugs Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Octreotide Drugs Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Octreotide Drugs Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Octreotide Drugs Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Octreotide Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Octreotide Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Octreotide Drugs Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Octreotide Drugs Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Octreotide Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Octreotide Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Octreotide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Octreotide Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Octreotide Drugs Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Octreotide Drugs Sales by Country (2025-2030) & (K Units)

Table 60. Europe Octreotide Drugs Sales by Type (2019-2024) & (K Units)

Table 61. Europe Octreotide Drugs Sales by Type (2025-2030) & (K Units)

Table 62. Europe Octreotide Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Octreotide Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Octreotide Drugs Sales by Application (2019-2024) & (K Units)

Table 65. Europe Octreotide Drugs Sales by Application (2025-2030) & (K Units)

Table 66. Europe Octreotide Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Octreotide Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Octreotide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Octreotide Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Octreotide Drugs Sales by Country (2019-2024) & (K Units)

Table 72. Europe Octreotide Drugs Sales by Country (2025-2030) & (K Units)

Table 73. China Octreotide Drugs Sales by Type (2019-2024) & (K Units)

Table 74. China Octreotide Drugs Sales by Type (2025-2030) & (K Units)

Table 75. China Octreotide Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Octreotide Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Octreotide Drugs Sales by Application (2019-2024) & (K Units)

Table 78. China Octreotide Drugs Sales by Application (2025-2030) & (K Units)

Table 79. China Octreotide Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Octreotide Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Octreotide Drugs Sales by Type (2019-2024) & (K Units)

Table 82. Asia Octreotide Drugs Sales by Type (2025-2030) & (K Units)

Table 83. Asia Octreotide Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Octreotide Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Octreotide Drugs Sales by Application (2019-2024) & (K Units)

Table 86. Asia Octreotide Drugs Sales by Application (2025-2030) & (K Units)

Table 87. Asia Octreotide Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Octreotide Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Octreotide Drugs Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Octreotide Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Octreotide Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Octreotide Drugs Sales by Region (2019-2024) & (K Units)

Table 93. Asia Octreotide Drugs Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Octreotide Drugs Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Octreotide Drugs Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Octreotide Drugs Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Octreotide Drugs Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Octreotide Drugs Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Octreotide Drugs Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Octreotide Drugs Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Octreotide Drugs Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Octreotide Drugs Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Octreotide Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Octreotide Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Octreotide Drugs Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Octreotide Drugs Sales by Country (2025-2030) & (K Units)

Table 107. Novartis Company Information

Table 108. Novartis Description and Major Businesses

Table 109. Novartis Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Novartis Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Novartis Recent Developments

Table 112. Sun Pharmaceutical Company Information

Table 113. Sun Pharmaceutical Description and Major Businesses

Table 114. Sun Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Sun Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Sun Pharmaceutical Recent Developments

Table 117. Teva Company Information

Table 118. Teva Description and Major Businesses

Table 119. Teva Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Teva Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 121. Teva Recent Developments

Table 122. Gland Pharma Company Information

Table 123. Gland Pharma Description and Major Businesses

Table 124. Gland Pharma Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Gland Pharma Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 126. Gland Pharma Recent Developments

Table 127. Chiesi Farmaceutici S.p.A Company Information

Table 128. Chiesi Farmaceutici S.p.A Description and Major Businesses

Table 129. Chiesi Farmaceutici S.p.A Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. Chiesi Farmaceutici S.p.A Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 131. Chiesi Farmaceutici S.p.A Recent Developments

Table 132. Fresenius Kabi Company Information

Table 133. Fresenius Kabi Description and Major Businesses

Table 134. Fresenius Kabi Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 135. Fresenius Kabi Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 136. Fresenius Kabi Recent Developments

Table 137. Mylan Company Information

Table 138. Mylan Description and Major Businesses

Table 139. Mylan Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 140. Mylan Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 141. Mylan Recent Developments

Table 142. Sagent Pharmaceuticals Company Information

Table 143. Sagent Pharmaceuticals Description and Major Businesses

Table 144. Sagent Pharmaceuticals Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 145. Sagent Pharmaceuticals Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 146. Sagent Pharmaceuticals Recent Developments

Table 147. West-Ward Pharmaceuticals Company Information

Table 148. West-Ward Pharmaceuticals Description and Major Businesses

Table 149. West-Ward Pharmaceuticals Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 150. West-Ward Pharmaceuticals Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 151. West-Ward Pharmaceuticals Recent Developments

Table 152. Suzhou Tianma Pharmaceutical Company Information

Table 153. Suzhou Tianma Pharmaceutical Description and Major Businesses

Table 154. Suzhou Tianma Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 155. Suzhou Tianma Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 156. Suzhou Tianma Pharmaceutical Recent Developments

Table 157. Sihuan Pharmaceutical Company Information

Table 158. Sihuan Pharmaceutical Description and Major Businesses

Table 159. Sihuan Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 160. Sihuan Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 161. Sihuan Pharmaceutical Recent Developments

Table 162. Chengdu Tiantaishan pharmaceutical Company Information

Table 163. Chengdu Tiantaishan pharmaceutical Description and Major Businesses

Table 164. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 165. Chengdu Tiantaishan pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 166. Chengdu Tiantaishan pharmaceutical Recent Developments

Table 167. Hybio Pharmaceutical Company Information

Table 168. Hybio Pharmaceutical Description and Major Businesses

Table 169. Hybio Pharmaceutical Octreotide Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 170. Hybio Pharmaceutical Octreotide Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 171. Hybio Pharmaceutical Recent Developments

Table 172. Key Raw Materials Lists

Table 173. Raw Materials Key Suppliers Lists

Table 174. Octreotide Drugs Distributors List

Table 175. Octreotide Drugs Customers List

Table 176. Octreotide Drugs Market Trends

Table 177. Octreotide Drugs Market Drivers

Table 178. Octreotide Drugs Market Challenges

Table 179. Octreotide Drugs Market Restraints

Table 180. Research Programs/Design for This Report

Table 181. Key Data Information from Secondary Sources

Table 182. Key Data Information from Primary Sources

List of Figures

Figure 1. Octreotide Drugs Product Picture

Figure 2. Global Octreotide Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Octreotide Drugs Market Share by Type: 2023 & 2030

Figure 4. Injections Product Picture

Figure 5. Oral Capsules Product Picture

Figure 6. Global Octreotide Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Octreotide Drugs Market Share by Application: 2023 & 2030

Figure 8. Neuroendocrine Tumors

Figure 9. Acromegaly

Figure 10. Other

Figure 11. Octreotide Drugs Report Years Considered

Figure 12. Global Octreotide Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 14. Global Octreotide Drugs Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Octreotide Drugs Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Octreotide Drugs Revenue Market Share by Region (2019-2030)

Figure 17. Global Octreotide Drugs Sales (2019-2030) & (K Units)

Figure 18. Global Octreotide Drugs Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 19. Global Octreotide Drugs Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Octreotide Drugs Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Octreotide Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Octreotide Drugs Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Octreotide Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Octreotide Drugs Sales YoY (2019-2030) & (K Units)

Figure 25. China Octreotide Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Octreotide Drugs Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Octreotide Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Octreotide Drugs Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Octreotide Drugs Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Octreotide Drugs Sales Share by Manufacturers (2023)

Figure 31. The Octreotide Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Octreotide Drugs Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Octreotide Drugs in the World: Market Share by Octreotide Drugs Revenue in 2023

Figure 34. Global Octreotide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Octreotide Drugs Sales Market Share by Type (2019-2030)

Figure 36. Global Octreotide Drugs Revenue Market Share by Type (2019-2030)

Figure 37. Global Octreotide Drugs Sales Market Share by Application (2019-2030)

Figure 38. Global Octreotide Drugs Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Octreotide Drugs Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Octreotide Drugs Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Octreotide Drugs Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Octreotide Drugs Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Octreotide Drugs Revenue Share by Country (2019-2030)

Figure 44. US & Canada Octreotide Drugs Sales Share by Country (2019-2030)

Figure 45. US Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Octreotide Drugs Sales Market Share by Type (2019-2030)

Figure 48. Europe Octreotide Drugs Revenue Market Share by Type (2019-2030)

Figure 49. Europe Octreotide Drugs Sales Market Share by Application (2019-2030)

Figure 50. Europe Octreotide Drugs Revenue Market Share by Application (2019-2030)

Figure 51. Europe Octreotide Drugs Revenue Share by Country (2019-2030)

Figure 52. Europe Octreotide Drugs Sales Share by Country (2019-2030)

Figure 53. Germany Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 54. France Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 58. China Octreotide Drugs Sales Market Share by Type (2019-2030)

Figure 59. China Octreotide Drugs Revenue Market Share by Type (2019-2030)

Figure 60. China Octreotide Drugs Sales Market Share by Application (2019-2030)

Figure 61. China Octreotide Drugs Revenue Market Share by Application (2019-2030)

Figure 62. Asia Octreotide Drugs Sales Market Share by Type (2019-2030)

Figure 63. Asia Octreotide Drugs Revenue Market Share by Type (2019-2030)

Figure 64. Asia Octreotide Drugs Sales Market Share by Application (2019-2030)

Figure 65. Asia Octreotide Drugs Revenue Market Share by Application (2019-2030)

Figure 66. Asia Octreotide Drugs Revenue Share by Region (2019-2030)

Figure 67. Asia Octreotide Drugs Sales Share by Region (2019-2030)

Figure 68. Japan Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 72. India Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Octreotide Drugs Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Octreotide Drugs Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Octreotide Drugs Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Octreotide Drugs Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Octreotide Drugs Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Octreotide Drugs Sales Share by Country (2019-2030)

Figure 80. Brazil Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Octreotide Drugs Revenue (2019-2030) & (US$ Million)

Figure 85. Octreotide Drugs Value Chain

Figure 86. Octreotide Drugs Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed